Abstract: Contextually placed chat-like annotations in an electronic record. Users can input successive time-stamped annotations at a selected location in an electronic record. The annotations are displayed chronologically in a discussion window, which is customizable by color, style, and location. The discussion window styles minimize clutter and distraction, thus providing for more effective review and collaboration. The discussion location is indicated by a discussion point icon, and can be displayed in a window of fixed sire with scrolling capability. A user can email the discussion window content to other users and request an alert, notifying the user of successive annotations. An annotation engine can reside on a server and receives user input and per functionality related to the annotations. The electronic record can reside on the server and is repeatedly updated to reflect current content relating to the electronic record and annotations.

Abstract: A network device has a housing, a magnetic induction charger, a wireless data link and a processor. The housing has one or more sides. The induction charger is housed by the housing and is arranged to wirelessly charge a rechargeable battery of a portable electronic device. The electronic device is adjacent to or in contact with the housing. The wireless data link communicates with the portable electronic device. The processor communicates with the magnetic induction charger and the wireless data link. In addition, the processor recognizes the portable electronic device and associates a profile with the portable electronic device. The processor delivers content to an associated media device based on the profile.

Abstract: A network device has a housing, a magnetic induction charger, a wireless data link and a processor. The housing has one or more sides. The induction charger is housed by the housing and is arranged to wirelessly charge a rechargeable battery of a portable electronic device. The electronic device is adjacent to or in contact with the housing. The wireless data link communicates with the portable electronic device. The processor communicates with the magnetic induction charger and the wireless data link. In addition, the processor recognizes the portable electronic device and associates a profile with the portable electronic device. The processor delivers content to an associated media device based on the profile.

Abstract: A network device has a housing, a magnetic induction charger, a wireless data link and a processor. The housing has one or more sides. The induction charger is housed by the housing and is arranged to wirelessly charge a rechargeable battery of a portable electronic device. The electronic device is adjacent to or in contact with the housing. The wireless data link communicates with the portable electronic device. The processor communicates with the magnetic induction charger and the wireless data link. In addition, the processor recognizes the portable electronic device and associates a profile with the portable electronic device. The processor delivers content to an associated media device based on the profile.

Abstract: A network device has a housing, a magnetic induction charger, a wireless data link and a processor. The housing has one or more sides. The induction charger is housed by the housing and is arranged to wirelessly charge a rechargeable battery of a portable electronic device. The electronic device is adjacent to or in contact with the housing. The wireless data link communicates with the portable electronic device. The processor communicates with the magnetic induction charger and the wireless data link. In addition, the processor recognizes the portable electronic device and associates a profile with the portable electronic device. The processor delivers content to an associated media device based on the profile.

Abstract: Contextually placed chat-like annotations in an electronic record. Users can input successive time-stamped annotations at a selected location in an electronic record. The annotations are displayed chronologically in a discussion window, which is customizable by color, style, and location. The discussion window styles minimize clutter and distraction, thus providing for more effective review and collaboration. The discussion location is indicated by a discussion point icon, and can be displayed in a window of fixed size with scrolling capability. A user can email the discussion window content to other users and request an alert, notifying the user of successive annotations. An annotation engine can reside on a server and receives user input and performs functionality related to the annotations. The electronic record can reside on the server and is repeatedly updated to reflect current content relating to the electronic record and annotations.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to humanized anti-B7-2 and anti-B7-1 antibodies, wherein each comprise a variable region of non-human origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to humanized anti-B7-2 and anti-B7-1 antibodies, wherein each comprise a variable region of non-human origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to humanized anti-B7-2 and anti-B7-1 antibodies, wherein each comprise a variable region of non-human origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.